Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of The Removal of Myoglobin With CytoSorb on The Endothelium and Glycocalyx Shedding Biomarkers in Patients With Rhabdomyolysis

NCT06503289 is registered in ClinicalTrials.gov with Sisli Hamidiye Etfal Training and Research Hospital as lead sponsor.

NCT NCT06503289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06503289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of The Removal of Myoglobin With CytoSorb on The Endothelium and Glycocalyx Shedding Biomarkers in Patients With Rhabdomyolysis
Lead sponsor
Sisli Hamidiye Etfal Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
August 1, 2024
Completion date
May 1, 2025
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, endothelial dysfunction, rhabdomyolysis